The announced restructuring measures at the Mainz biotechnology company Biontech raise new questions regarding the long-term future of the headquarters. After the management announced in May the closure of the production and research sites in Idar-Oberstein, Marburg, Wiesbaden and Tübingen by the end of 2027, the organizational interdependencies with the Group headquarters in Mainz are now moving into the [...] The contribution Structural change…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The announced restructuring measures at the Mainz biotechnology company Biontech raise new questions regarding the long-term future of the headquarters. After the management announced in May the closure of the production and research sites in Idar-Oberstein, Marburg, Wiesbaden and Tübingen by the end of 2027, the organizational interdependencies with the Group headquarters in Mainz are now moving into the [...] The contribution Structural change…